Literature DB >> 12209580

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.

Christian Hafner1, Ruth Knuechel, Robert Stoehr, Arndt Hartmann.   

Abstract

Multifocal occurrence and frequent recurrence are characteristic features of urothelial carcinomas of both the urinary bladder and the upper urinary tract. To describe the clonal nature of these tumors, 2 theories have been proposed. The monoclonality hypothesis describes the multiple tumors as descendants of a single genetically transformed cell spreading throughout the urothelium. In contrast, field cancerization caused by carcinogen exposure of the urothelium may lead to independent development of synchronous or metachronous nonrelated tumors at different sites of the urothelial tract. In the last 10 years, a multitude of molecular genetic studies have investigated the clonality of multifocal urothelial carcinomas. The majority of studies revealed a monoclonal origin of the multiple tumors. However, most of these studies investigated advanced invasive carcinomas. A small but significant proportion of multifocal urothelial carcinomas appear to arise from different clones, supporting the field-cancerization hypothesis. Oligoclonal tumors might be more common in precursor lesions and early tumor stages. The frequent monoclonality found in patients with advanced tumors could be due to outgrowth of 1 tumor cell clone with specific genetic alterations. Two important mechanisms appear to be important for the spread of malignant cells: intraluminal seeding and intraepithelial migration. Investigation of the entire urothelial lining in patients with urothelial tumors should provide further insight into the development of multifocal urothelial carcinomas. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209580     DOI: 10.1002/ijc.10544

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.

Authors:  Qilai Long; Tzu-Yin Lin; Yee Huang; Xiaocen Li; Ai-Hong Ma; Hongyong Zhang; Randy Carney; Susan Airhart; Kit S Lam; Ralph W deVere White; Chong-Xian Pan; Yuanpei Li
Journal:  Nanomedicine       Date:  2018-01-06       Impact factor: 5.307

Review 2.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

3.  Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

Authors:  Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Comparison of properties of tests for assessing tumor clonality.

Authors:  Irina Ostrovnaya; Venkatraman E Seshan; Colin B Begg
Journal:  Biometrics       Date:  2008-02-11       Impact factor: 2.571

5.  Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.

Authors:  Ken Kikuchi; Takeshi Shigihara; Yuko Hashimoto; Masayuki Miyajima; Nobuhiro Haga; Yoshiyuki Kojima; Fumio Shishido
Journal:  Fukushima J Med Sci       Date:  2017-07-05

6.  Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints.

Authors:  Costantino Errani; Yun Shao Sung; Lei Zhang; John H Healey; Cristina R Antonescu
Journal:  Cancer Genet       Date:  2012 Jan-Feb

Review 7.  Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.

Authors:  David R Yates; James W F Catto
Journal:  World J Urol       Date:  2012-09-18       Impact factor: 4.226

Review 8.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

9.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

10.  Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.

Authors:  Karsten Zieger; Carsten Wiuf; Klaus Møller-Ernst Jensen; Torben Falck Ørntoft; Lars Dyrskjøt
Journal:  BMC Cancer       Date:  2009-05-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.